Drugs used in heart failure Flashcards
1
Q
Digitalis glycosides and its mechanism
A
- Digoxin - most widely used
- Positive inotropics
- Enhance cardiac muscle contractility and, thus increase CO by increased cytoplasmic calcium concentration
- Inhibit Na/K ATPase –> cause increse in intracellular Na
- Incresed Na, decreases the driving force for the Na/Ca exchanger –> increased intracellular Ca
- The resting membrane potential may increase (-70mV)
2
Q
Cardiac effects of glycosides
A
- Increased ventricular ejection
- Decreased end-systolic and end-diastolic size
- Increased CO
- Increased renal perfusion
- Compensatory it will decrease sympathetic outflow –> decrease HR, preload and afterload
- The myocardial oxygen demand will diminish
3
Q
Digoxin
A
- Digitalis glycoside
- Positiv inotropic effect
- Indicated in patients with severe left ventricular systolic dysfunction
- Treatment of chronic HF
- Major indications is HF with AF
- Quinidine increase digoxin serum levels
4
Q
Electrical effect of glycosides
A
- Increase PR interval
- Flattening of T wave
- Shortened QT, inversion of the T, and ST depression may occur later
- Increased automaticity is a toxic effect –> may evoke extrasystoles, tachycardia or fibrillation
- Its effect is inhibited by increased extracellular potassium and magnesium, and enhanced by increased extracellular calcium
5
Q
Positive inotropic drugs
A
- Digitalis glycosides: Digoxin
- Beta-Adrenergic agonists: Dobutamine
- Phospodiesterase inhibitors: Inamrinone, Milrinone
6
Q
Beta-Adrenergic agonists
A
- Dobutamine
- Most commonly used inotropic agent after Digoxin
- Increase the intracellular cAMP, which results in the activation of protein kinase
- Activated protein kinase phosphorylates a Ca-channel, which increases calcium flow into the cell, thereby enhancing contraction
- IV infusion
- Primarly used in treatment of acute HF in hospital
7
Q
Phosphodiesterase inhibitors
A
- Inamrinone, Milrinone
- Prevent hydrolysis of cAMP and, thus, prolong the action of protein kinase
- Activated protein kinase, phosphorylates a Ca-channel, which increases calcium flow into the cell, thereby enhancing contraction
- Also cause vasodilation
- Long-term therapy increase morbidity and mortality, and should therefor not be used in CHF
8
Q
ACE inhibitors and their mechanism
A
- Captopril, Enalapril, Fosinopril, Lisinopril, Quinpril, Ramipril
- Block angiotensin-converting enzyme (ACE), that cleaves Angiotensin I to the potent vasoconstrictor Angiotensin II
- Also inhibit degradation of the potent vasodilator bradykinin
- Decrease secretion of aldosterone, resulting in decreased sodium and water retention
9
Q
ACE inhibitors; cardiac actions
A
- Decrease vascular resistance, venous tone, and blood pressure
- Reduce preload and afterload –> increased CO
10
Q
ACE inhibitors; indications
A
- Considered, along with diuretics, among the first-line drugs for CHF
- Indicated in patients with all stages of left ventricular failure
- May be used as single-agent therapy in patient with mild dyspnea on exertion and do not have edema
- It is recommended that ACE inhibitors be initiated immediately after MI
- Contraindicated in pregnancy
11
Q
ACE inhibitors; adverse effects
A
- Postural hypotension
- Renal insufficiency
- Hyperkalemia
- Angioedema
- Persisten dry cough
12
Q
Positive inotropic drugs
A
- Digitalis glycosides: Digoxin
- β-Adrenergic agonists: Dobutamine
- Phospodiesterase inhibitors: Inamrinone, Milrinone
13
Q
β-Adrenergic agonists
A
- Dobutamine
- Most commonly used inotropic agent after Digoxin
- Increase the intracellular cAMP, which results in the activation of protein kinase
- Activated protein kinase phosphorylates a Ca-channel, which increases calcium flow into the cell, thereby enhancing contraction
- IV infusion
- Primarly used in treatment of acute HF in hospital
14
Q
Angiotensin-receptor blockers (ARBs) and their mechanism
A
- Losartan, Candesertan, Telmisartan, Valsartan
- Competetive antagonists of the angiotensin type 1 receptor
- Do not affect bradykinin levels
- Adverse effects: Postural hypotension, renal insuffiency, hyperkalemia
15
Q
ARBs; indications
A
- Treatment of hypertension
- Use in HF is as a substitute for ACE inhibitors in patients with severe cough or angioedema
- Contraindicated in pregnancy
16
Q
Carvedilol
A
- Nonselective β-blocker
- Also block α1-adrenoreceptors
- Reduce morbidity and mortality in patients with HF
17
Q
Diuretics
A
- Loop diuretics (Furosemide) most commonly used diuretic in HF
- Thiazides (Hydrochlorothiazide) are sometimes sufficient for mild CHF
- Relieve pulmonary congestion and peripheral edema
- Decrease preload –> decrease cardiac workload and the oxygen demand
18
Q
β-blockers
A
- Atenolol, Carvedilol, Metoprolol
- Decrese HR and inhibit release of renin
- Prevent the direct deleterious effects of NE on the cardiac muscle fibers
- Decrease remodelig, hypertrophy, and cell death
- Recommended for all patients with heart disease, except those who are at high risk but with no symptoms and those with acute HF
19
Q
Vasodilators
A
- Nitroprusside, Nitroglycerin, Hydralazine, Isosorbide dinitrate
- Dilation of venous vessels –> decrease preload
- Dilation of arterial vessels –> decrease afterload
- Nitrates are commonly used in congestive HF
- Hydralazine and Isosorbide dinitrate used in CHF
20
Q
Aldosterone antagonists
A
- Spironolactone
- Direct antagonist of aldosterone
- Prevent salt retention, myocardial hypertrophy, and hypokalemia
- Reserved for the most severe cases of HF
- Adverse effects: GI disurbances (ulcers), CNS effects (confusion, lethargy), endocrine abnormalites (decreased libido, gynecomastia)
21
Q
Order of therapy in CHF
A
- Loop diuretics to relieve signs or symptoms of volume overload
- ACE inhibitors (or ARBs if ACE not tolerated)
- β-blockers
- Digoxin (or other positive inotropic drugs)
22
Q
Order of therapy in AHF
A
- Loop diuretic
- Positive inotropic agent
- Vasodilators
23
Q
Prophylaxis against endocarditis
A
- S. Aureus and S. Epidermidis
1. Cafazolin (before and 3-4 times after surgery)
2. Clindamycin (before/after dental extraction)
3. Metronidazole (before/after dental extraction)
24
Q
Therapy for endocarditis
A
- Ampicyllin + Sulbactam + Gentamycin
- Vancomycin + Gentamycin + Ciprofloxacin
- Vancomycin + Gentamycin + RMF
25
Q
AMI therapy
A
- Morphine - iv. 2-4 mg every 5 min
- O2 - 4L/min
- Nitroglycerin - sl. or iv. infusion
- ASA - po. 325 mg
- Reperfusion - Heparin or LMWH, streptokinase or t-PA
- Beta-blocker
- ACE-inhibitor